Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
![]() |
Boston ScientificBSX |
-$2.03B |
![]() |
MedtronicMDT |
-$93M |
![]() |
Edwards LifesciencesEW |
-$364M |
![]() |
Intuitive SurgicalISRG |
-$1.36B |
![]() |
MedpaceMEDP |
-$66.9B |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Menawat Arun Swarup | May 16, 2025 | Buy | 12,027 | $4.73 | $57,000 |
| Menawat Arun Swarup | May 15, 2025 | Buy | 10,003 | $4.325 | $43,000 |
FAQ - Insider Transactions
The most recent insider transaction for Profound Medical Corp was conducted by Menawat Arun Swarup, who sold 12,027 shares on May 16, 2025 at a price of $4.73 per share.
Menawat Arun Swarup has bought the most PROF stock in the last 2 years, with a total value of $100,000.
According to our estimates, the total value of insider transactions for Profound Medical Corp in the last 2 years is positive, amounting to $100,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
Over the last 2 years, insider transactions for Profound Medical Corp have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.




